DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

A new study reveals a staggering number of elderly Americans experiencing cognitive decline continue to drive, raising ...

In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, particularly in women. Levels were found to drop gradually, from women with ...

Daily treatment with 1200 mg of choline alfoscerate showed marginal improvement in cognitive function in patients with T2D ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

Higher green tea consumption significantly reduces cerebral white matter lesions in older adults, offering potential ...

In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to predict the onset age of mild cognitive impairment and Alzheimer ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...